Long-acting beta-agonists (LTBAs) received a Black Box warning from the U.S.Food and Drug Administration due to the:
A) Risk of life-threatening dermatological reactions
B) Increased incidence of cardiac events when LTBAs are used
C) Increased risk of asthma-related deaths when LTBAs are used
D) Risk for life-threatening alterations in electrolytes
Correct Answer:
Verified
Q1: The bronchodilator of choice for patients taking
Q11: Patients with pheochromocytoma should avoid which of
Q12: When recommending dimenhydrinate (Dramamine) to treat motion
Q12: Martin is a 60 year old with
Q13: Montelukast (Singulair)may be prescribed for:
A) A 6
Q15: Christy has exercise and mild persistent asthma
Q18: When educating patients who are starting on
Q18: Decongestants such as pseudoephedrine (Sudafed):
A) Are Schedule
Q19: James is a 52-year-old overweight smoker taking
Q21: The first-line treatment for cough related to
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents